Professor David Price
Chair of Primary Care Respiratory Med
- About
-
- Email Address
- d.price@abdn.ac.uk
- Telephone Number
- +44 (0)1224 437237
- School/Department
- School of Medicine, Medical Sciences and Nutrition
- Publications
-
Page 57 of 93 Results 561 to 570 of 923
Predicting frequent asthma exacerbations using blood eosinophil count and other patient data routinely available in clinical practice
Journal of Asthma and Allergy, vol. 9, pp. 1-12Contributions to Journals: ArticlesInhaled corticosteroid dose-response on blood eosinophils in asthma: Authors' reply
The Lancet. Respiratory medicine, vol. 4, no. 1, pp. e1-e2Contributions to Journals: Comments and Debates- [ONLINE] DOI: https://doi.org/10.1016/S2213-2600(15)00506-8
Are pharmacological randomised controlled clinical trials relevant to real-life asthma populations?: A protocol for an UNLOCK study from the IPCRG
npj Primary Care Respiratory Medicine, vol. 26, pp. 1-3Contributions to Journals: ArticlesAsthma in Asia: Physician perspectives on control, inhaler use and patient communications
Journal of Asthma, vol. 53, no. 7, pp. 761-769Contributions to Journals: ArticlesAsthma-specific health related quality of life of people in Great Britain: A national survey
Journal of Asthma, vol. 53, no. 9, pp. 975-982Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.3109/02770903.2016.1166383
Changes in initial COPD treatment choice over time and factors influencing prescribing decisions in UK primary care: a real-world study
npj Primary Care Respiratory Medicine, vol. 26, 16002Contributions to Journals: Review articles- [ONLINE] DOI: https://doi.org/10.1038/npjpcrm.2016.2
- [OPEN ACCESS] http://aura.abdn.ac.uk/bitstreams/6368b22a-e385-432c-9788-ef24e3031244/download
- [ONLINE] View publication in Scopus
Effectiveness of allergic rhinitis treatments in real-life with a focus on MP-AzeFlu
Expert Review of Clinical Pharmacology, vol. 9, no. 5, pp. 705-714Contributions to Journals: Literature Reviews- [ONLINE] DOI: https://doi.org/10.1586/17512433.2016.1148598
Safety evaluation of MP29-02 (a novel intranasal formulation of azelastine hydrochloride and fluticasone propionate) for allergic rhinitis
Expert Opinion on Drug Safety, vol. 15, no. 1, pp. 117-129Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.1517/14740338.2016.1122755
- [ONLINE] View publication in Scopus
The Relationship Between 24-Hour Symptoms and COPD Exacerbations and Healthcare Resource Use: Results from an Observational Study (ASSESS)
COPD: Journal of Chronic Obstructive Pulmonary Disease, vol. 13, no. 5, pp. 561-568Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.3109/15412555.2016.1150447
- [ONLINE] View publication in Scopus
UK prescribing practices as proxy markers of unmet need in allergic rhinitis: a retrospective observational study
npj Primary Care Respiratory Medicine, vol. 26, pp. 1-8Contributions to Journals: Articles